Biotage AB (publ) Year-end report January – December 2021

Strong growth, both organic and acquired   October–December  · Net sales amounted to SEK 341 (298) million, an increase of 14.5 percent and an organic* growth of 10.0 percent. · The operating profit amounted to SEK 61 (60) million, and adjusted to SEK 70 (60) million. · The operating margin was 18.0 percent (20.0), and adjusted was 20.7 percent (20.0). · EBITA* amounted to SEK 67 (62) million, and adjusted to SEK 76 (62) million. · EBITA margin* was 19.5 percent (20.9) and adjusted was 22.2 percent (20.9). · Profit after tax amounted to SEK 46 (44) million.  ·